John Gans Email and Phone Number

Rare and Ultra-Rare Disease SalesDuchenne Muscular DystrophyGene Therapy-Aromatic L-amino acid decarboxylase (AADC) deficiency is a genetic condition that affects the communication between the brain and other parts of the body causing development delays.Pediatric Neurology and geneticist focusedMinnesota, Michigan, Indiana, North & South Dakota

Recruited back to Amgen to launch new buy & bill product in the dialysis space. Three time Chairman’s Circle Award Winner (top 10%)

Rare disease sales representative covering Minnesota, North & South Dakota. Position entails marketing a speciality injectable product, NATPARA, to Endocrinologists for the rare disease, HypoParathyroidism. Product is distributed via a REMS through a limited speciality pharmacy network requiring provider certification and staff training prior to utilization. Finished first year post launch ranked 5 of 50 in nation.

NPS acquired by Shire February 2015.

Direct contract sales to buy and bill physician offices, hospitals, community and teaching, in Minnesota and North Dakota. Sales to kidney dialysis units, Rheumatology offices, and multi-specialty clinics. TNF inhibiter Enbrel, injectable recombinant human erythropoietin, and parathyroid hormone products.Oncologists, Rheumatologists, Nephrologists, and Endocrinologists as customer base.Previous roles included District Sales Trainer.Regional contract and reimbursement expert.Regional business acumen expert. Three time Chairman’s Circle Award Winner (top 10%)

Injectable anti-thrombotic sales to teaching hospitals, large trauma hospitals.Call points included: interventional cardiology, cath-lab, orthopedic surgeons, oncologists.